As Tilray Brands' stock languishes near multi-year lows, a deep dive into its valuation metrics suggests a significant discount. But with the cannabis sector facing headwinds, is this a genuine opportunity for investors, or a sign of deeper troubles?
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
A wave of protests and student walkouts swept across the United States on Friday, demanding the withdrawal of federal immigration agents from Minnesota following fatal shootings, as political tensions threaten a government shutdown.
The Federal Reserve's decision to maintain its benchmark rate signals underlying economic strength, leaving mortgage rates largely unmoved. While affordability challenges persist, a gradual rebalancing of the market offers cautious optimism for buyers and sellers.
New market data reveals a stark generational divide in American drinking habits, with Gen Z contributing a mere 4% to total alcohol sales last year. The findings challenge long-held industry assumptions and highlight the enduring spending power of older consumers amid a broader shift toward premiumization and alternative beverages.
Facing a looming wave of retirements, independent advisory firms are increasingly turning to employee ownership and sophisticated tax strategies to secure their futures, offering an alternative to the private equity buyout.
Capgemini faces mounting scrutiny after its U.S. subsidiary signed a contract with Immigration and Customs Enforcement (ICE), sparking ethical debates in France and raising questions about governance risks for the IT consulting giant.
NextEra Energy's unique dual-business model offers investors the stability of a regulated utility alongside the high-growth potential of its renewable energy arm, positioning it as a key player in powering the AI boom.
A baseless rumor about a potential Osaic-Cetera merger, which spread rapidly through advisor networks, has highlighted the intense pressures and sometimes questionable tactics in today's financial advisor recruiting landscape.
Amid a sharp drop in annual profits, Chevron and Exxon Mobil chart starkly different courses on Venezuela's oil potential, highlighting the industry's split response to geopolitical risk and economic uncertainty.
UBS Group's shares have retreated from recent highs, prompting investors to weigh its current price against robust multi-year performance and the ongoing integration of Credit Suisse. Is the Swiss banking giant fairly valued, or is the market overlooking future risks?
InterDigital (NASDAQ: IDCC) has laid out an ambitious financial roadmap for fiscal year 2026, forecasting revenues up to $775 million. The outlook is supported by a newly inked licensing agreement with LG Electronics and a key smartphone renewal, signaling strong momentum in its patent portfolio.
The new year kicked off with significant personnel changes in the human resources executive suite, highlighting strategic expansions of roles and notable returns to former companies.
Former CNN anchor Don Lemon faces federal charges under the Freedom of Access to Clinic Entrances (FACE) Act after a protest at a Minnesota church, marking a rare application of the law beyond abortion clinic demonstrations and raising First Amendment questions.
With low adoption rates for brokerage 'trusted contacts,' regulators are considering a simple name change to 'emergency contact' to reduce confusion, ease client concerns, and strengthen protections against financial exploitation.
Investors face a classic choice between AbbVie's steady dividends and Abivax's high-risk, high-reward potential as both target lucrative immunology markets.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
As the cryptocurrency market grapples with sustained selling pressure, a new analysis highlights significant vulnerabilities for two of the most recognizable digital assets, XRP and Dogecoin, projecting potential losses exceeding 50% in the coming year.
Baidu's flagship AI assistant, Ernie, has surpassed 200 million monthly active users, a milestone reported by the Wall Street Journal. The growth underscores Baidu's deepening integration of AI across its ecosystem amid fierce competition with domestic tech rivals.
The Optimism Collective has unveiled OP Enterprise, a comprehensive blockchain infrastructure platform designed to give financial technology firms and institutions direct control over revenue and operations. The launch signals a pivotal shift towards institutional-grade Web3 solutions as regulatory clarity emerges.
